Science Explorer Back to mapMap
Discussion
Institution · Buffalo Psychiatric Center

Most cited papers from Buffalo Psychiatric Center

Buffalo Psychiatric Center

What are the most cited papers from Buffalo Psychiatric Center?

The most cited paper from Buffalo Psychiatric Center is "Protection Against Cerebral Embolism During Transcatheter Aortic Valve Replacement" (Samir Ramesh Kapadia et al., 2016), with 513 citations. Next come "The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative" (428) and "Effect of a Cerebral Protection Device on Brain Lesions Following Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Stenosis" (374).

Showing 50 of 60 papers. Every paper with more than 83 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Protection Against Cerebral Embolism During Transcatheter Aortic Valve Replacement Samir Ramesh Kapadia et al. · Journal of the American College of Cardiology Open access Nov 2016 513
2 The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative on behalf of the NAIMS Cooperative et al. · Nature Reviews Neurology ReviewOpen access 11 Nov 2016 428
3 Effect of a Cerebral Protection Device on Brain Lesions Following Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Stenosis Stephan Haußig, Norman Mangner, Michael G. Dwyer et al. · JAMA Open access 9 Aug 2016 374
4 Overview of quantitative susceptibility mapping Andreas Deistung, Ferdinand Schweser, Jürgen Rainer Reichenbach · NMR in Biomedicine 19 Jul 2016 350
5 Validity of the Beck Depression Inventory-Fast Screen in multiple sclerosis Ralph H. B. Benedict, Inna Fishman, Michelle McClellan et al. · Multiple Sclerosis Journal Aug 2003 337
6 Neocortical Atrophy, Third Ventricular Width, and Cognitive Dysfunction in Multiple Sclerosis Ralph H. B. Benedict, Jared M. Bruce, Michael G. Dwyer et al. · Archives of Neurology Sep 2006 301
7 Quantitative Susceptibility Mapping in Parkinson's Disease Christian Langkammer, Lukas Pirpamer, Stephan Seiler et al. · PLoS ONE Open access 6 Sep 2016 248
8 Three times weekly glatiramer acetate in relapsing–remitting multiple sclerosis Omar Khan, Peter Rieckmann, Alexey Boyко et al. · Annals of Neurology 20 May 2013 221
9 Quantitative susceptibility mapping: Report from the 2016 reconstruction challenge Christian Langkammer, Ferdinand Schweser, Karin Shmueli et al. · Magnetic Resonance in Medicine Open access 31 Jul 2017 200
10 Memory impairment in multiple sclerosis: correlation with deep grey matter and mesial temporal atrophy Ralph H. B. Benedict, Deepa Preeti Ramasamy, F. E. Munschauer et al. · Journal of Neurology Neurosurgery & Psychiatry Oct 2008 198
11 Prevalence, sensitivity, and specificity of chronic cerebrospinal venous insufficiency in MS Robert Zivadinov, Karen Marr, Gary Cutter et al. · Neurology 14 Apr 2011 190
12 Abnormal subcortical deep-gray matter susceptibility-weighted imaging filtered phase measurements in patients with multiple sclerosis Robert Zivadinov, Mari Heininen‐Brown, Claudiu V. Schirda et al. · NeuroImage Aug 2011 189
13 Brain atrophy and disability progression in multiple sclerosis patients: a 10-year follow-up study Cecilie Jacobsen, Jesper Hagemeier, Kjell-Morten Myhr et al. · Journal of Neurology Neurosurgery & Psychiatry Open access 19 Feb 2014 183
14 The relationship between whole brain volume and disability in multiple sclerosis: A comparison of normalized gray vs. white matter with misclassification correction Michael P. Sanfilipo, Ralph H. B. Benedict, Jitendra Sharma et al. · NeuroImage 21 Apr 2005 176
15 Single pass sequencing and physical and genetic mapping of human brain cDNAs Akbar S. Khan, Andrea S. Wilcox, Mihael H. Polymeropoulos et al. · Nature Genetics Nov 1992 173
16 Interferon β for Multiple Sclerosis Dejan Jakimovski, Channa Kolb, Murali Krishna Ramanathan et al. · Cold Spring Harbor Perspectives in Medicine Open access 8 Jan 2018 172
17 Gray Matter Atrophy in Patients With Ischemic Stroke With Cognitive Impairment Glenn T. Stebbins, David L. Nyenhuis, Changsheng Wang et al. · Stroke 8 Feb 2008 168
18 Retinal nerve fiber layer thickness is associated with brain MRI outcomes in multiple sclerosis Erica Grazioli, Robert Zivadinov, Bianca Weinstock‐Guttman et al. · Journal of the Neurological Sciences 6 Dec 2007 168
19 Brain CT and MRI Findings in 100 Consecutive Patients with Intracranial Tuberculoma Mohammad Wasay, Bhojo A. Kheleani, Mahesh K. Moolani et al. · Journal of Neuroimaging Jul 2003 166
20 A study of mefloquine treatment for progressive multifocal leukoencephalopathy: results and exploration of predictors of PML outcomes David B. Clifford, Avindra Nath, Paola Cinque et al. · Journal of NeuroVirology Open access 3 Jun 2013 165
21 Proposed Standardized Neurological Endpoints for Cardiovascular Clinical Trials Alexandra J. Lansky et al. · Journal of the American College of Cardiology Open access Feb 2017 162
22 Thalamic Atrophy Is Associated with Development of Clinically Definite Multiple Sclerosis Robert Zivadinov, Eva Havrdová, Niels Bergsland et al. · Radiology 24 Apr 2013 162
23 Subcortical and Cortical Gray Matter Atrophy in a Large Sample of Patients with Clinically Isolated Syndrome and Early Relapsing-Remitting Multiple Sclerosis Niels Bergsland, Dana Horáková, Michael G. Dwyer et al. · American Journal of Neuroradiology Open access 12 Apr 2012 159
24 An illustrated comparison of processing methods for MR phase imaging and QSM: combining array coil signals and phase unwrapping Simon Robinson, Kristian Bredies, Diana Khabipova et al. · NMR in Biomedicine Open access 13 Sep 2016 155
25 Recommended implementation of quantitative susceptibility mapping for clinical research in the brain: A consensus of the ISMRM electro‐magnetic tissue properties study group Berkin Bilgiç, Mauro Costagli, Kwok‐Shing Chan et al. · Magnetic Resonance in Medicine Open access 21 Jan 2024 147
26 Cardiovascular risk factors are associated with increased lesion burden and brain atrophy in multiple sclerosis Natalie Kappus, Bianca Weinstock‐Guttman, Jesper Hagemeier et al. · Journal of Neurology Neurosurgery & Psychiatry 26 Feb 2015 146
27 Extent of cerebellum, subcortical and cortical atrophy in patients with MS Deepa Preeti Ramasamy, Ralph H. B. Benedict, Jennifer L. Cox et al. · Journal of the Neurological Sciences 7 Feb 2009 140
28 Clinical–Magnetic Resonance Imaging Correlations in Multiple Sclerosis Robert Zivadinov, Thomas P. Leist · Journal of Neuroimaging Oct 2005 134
29 Lipid profiles are associated with lesion formation over 24 months in interferon-β treated patients following the first demyelinating event Bianca Weinstock‐Guttman, Robert Zivadinov, Dana Horáková et al. · Journal of Neurology Neurosurgery & Psychiatry 17 Apr 2013 124
30 Relationship of optic nerve and brain conventional and non-conventional MRI measures and retinal nerve fiber layer thickness, as assessed by OCT and GDx: A pilot study Elliot M. Frohman, Michael G. Dwyer, Teresa C. Frohman et al. · Journal of the Neurological Sciences 13 May 2009 124
31 Selective caudate atrophy in multiple sclerosis: a 3D MRI parcellation study Robert A. Bermel, Martins Innus, Christopher W. Tjoa et al. · Neuroreport Mar 2003 113
32 Independent contributions of cortical gray matter atrophy and ventricle enlargement for predicting neuropsychological impairment in multiple sclerosis Ayda Tekok-Kılıç, Ralph H. B. Benedict, Bianca Weinstock‐Guttman et al. · NeuroImage 19 Apr 2007 113
33 Brain iron accumulation in aging and neurodegenerative disorders Jesper Hagemeier, Jeroen J.G. Geurts, Robert Zivadinov · Expert Review of Neurotherapeutics Dec 2012 112
34 Preservation of gray matter volume in multiple sclerosis patients with the Met allele of the rs6265 (Val66Met) SNP of brain-derived neurotrophic factor Robert Zivadinov, Bianca Weinstock‐Guttman, Ralph H. B. Benedict et al. · Human Molecular Genetics 26 Jul 2007 107
35 Evolution of Cortical and Thalamus Atrophy and Disability Progression in Early Relapsing-Remitting MS during 5 Years Robert Zivadinov, Niels Bergsland, Ondřej Doležal et al. · American Journal of Neuroradiology Open access 11 Apr 2013 107
36 Clinical significance of atrophy and white matter mean diffusivity within the thalamus of multiple sclerosis patients Ralph H. B. Benedict, Hanneke E. Hulst, Niels Bergsland et al. · Multiple Sclerosis Journal 4 Mar 2013 106
37 Gray matter pathology in (chronic) MS: Modern views on an early observation Jeroen J.G. Geurts, Peter K. Stys, Alireza Minagar et al. · Journal of the Neurological Sciences Open access 27 Feb 2009 105
38 Can imaging techniques measure neuroprotection and remyelination in multiple sclerosis? Robert Zivadinov · Neurology 29 May 2007 105
39 Randomized Evaluation of TriGuard 3 Cerebral Embolic Protection After Transcatheter Aortic Valve Replacement Tamim M. Nazif, Jeffrey J. Moses, Rahul P. Sharma et al. · JACC: Cardiovascular Interventions Open access Mar 2021 102
40 Prediction of Longitudinal Brain Atrophy in Multiple Sclerosis by Gray Matter Magnetic Resonance Imaging T2 Hypointensity Robert A. Bermel, Srinivas Reddy Puli, Richard A. Rudick et al. · Archives of Neurology Open access Sep 2005 101
41 Utility of the Personality Diagnostic Questionnaire—Revised in A Nonclinical Population Jeffrey G. Johnson, Robert F. Bornstein · Journal of Personality Disorders Dec 1992 97
42 EMDR and CBT for Cancer Patients: Comparative Study of Effects on PTSD, Anxiety, and Depression Liuva Capezzani, Luca Ostacoli, Marco Cavallo et al. · Journal of EMDR Practice and Research 2013 95
43 Neurofilament levels are associated with blood–brain barrier integrity, lymphocyte extravasation, and risk factors following the first demyelinating event in multiple sclerosis Tomáš Uher, Mason McComb, Shery Galkin et al. · Multiple Sclerosis Journal 7 Apr 2020 94
44 First versus repeat treatment with a lifestyle intervention program: attendance and weight loss outcomes Elizabeth M. Venditti, George A. Bray, M L Carrion-Petersen et al. · International Journal of Obesity Open access 19 Aug 2008 94
45 Hypoperfusion of brain parenchyma is associated with the severity of chronic cerebrospinal venous insufficiency in patients with multiple sclerosis: a cross-sectional preliminary report Paolo Zamboni, Erica Menegatti, Bianca Weinstock‐Guttman et al. · BMC Medicine Open access 7 Mar 2011 93
46 Validity of the Wisconsin Card Sorting and Delis–Kaplan Executive Function System (DKEFS) Sorting Tests in multiple sclerosis Brett A. Parmenter, Robert Zivadinov, Laura Kerenyi et al. · Journal of Clinical and Experimental Neuropsychology 30 Nov 2006 93
47 Screening for alcohol-related problems in an outpatient obstetric-gynecologic clinic Marcia Russell, Lewis Bigler · American Journal of Obstetrics and Gynecology May 1979 93
48 Potential involvement of the extracranial venous system in central nervous system disorders and aging Robert Zivadinov, Chih‐Ping Chung · BMC Medicine Open access Dec 2013 92
49 Subcortical Atrophy Is Associated with Cognitive Impairment in Mild Parkinson Disease: A Combined Investigation of Volumetric Changes, Cortical Thickness, and Vertex-Based Shape Analysis Elijah E Mak, Niels Bergsland, Michael G. Dwyer et al. · American Journal of Neuroradiology Open access 31 Jul 2014 91
50 Verbal memory is associated with structural hippocampal changes in newly diagnosed Parkinson's disease Mona Kristiansen Beyer, Kolbjørn Brønnick, Kristy Hwang et al. · Journal of Neurology Neurosurgery & Psychiatry Open access 15 Nov 2012 91

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.